Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21390,193,1.49 [1.21-1.85],0.0002180389576985
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22583,242,0.94 [0.78-1.14],0.5515026912622985
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22311,1728,1.25 [1.16-1.34],2.3177812117145416e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Candidiasis,22587,535,1.23 [1.08-1.40],0.0017887368876268
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21842,4148,1.21 [1.16-1.27],9.517002911349188e-16
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21785,4213,1.24 [1.18-1.30],8.096690829624813e-20
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22302,1402,1.23 [1.13-1.33],7.583879028961535e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22493,125,0.96 [0.74-1.25],0.7582126117329433
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19828,1275,1.34 [1.23-1.46],1.0669235376241638e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19131,1549,1.42 [1.31-1.53],1.7684052199351894e-19
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,18636,332,1.44 [1.22-1.69],1.3559322266659503e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14704,2682,1.23 [1.16-1.31],4.191771348797078e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18583,487,1.52 [1.33-1.74],7.408407707921595e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22565,1665,1.21 [1.12-1.30],6.555943210051191e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Mycoses,22679,627,1.25 [1.11-1.41],0.000220545459947
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21808,1225,1.26 [1.16-1.37],1.0505820881520109e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22607,1410,1.34 [1.24-1.45],5.566508143907579e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21142,242,0.96 [0.79-1.16],0.660053419931428
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,22738,66,1.33 [0.92-1.92],0.1300839471981996
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22427,1230,1.32 [1.21-1.43],2.6004744850847006e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22447,79,0.81 [0.60-1.09],0.1681165015042061
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other viral diseases,22674,135,1.24 [0.96-1.60],0.1042483751655385
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22655,116,1.13 [0.86-1.50],0.3724757836967527
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21077,494,1.47 [1.28-1.67],2.011098768411132e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,20889,306,1.28 [1.08-1.52],0.004638286864569
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21040,140,1.56 [1.21-2.02],0.0005597024872885
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,22723,50,1.40 [0.92-2.11],0.1132678390654704
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,22671,162,1.18 [0.93-1.49],0.1765197673520063
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral warts,22561,52,0.95 [0.63-1.42],0.7889239410652099
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],22581,72,1.12 [0.79-1.59],0.5329212762203257
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm,22452,264,0.91 [0.76-1.09],0.3016829356907604
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,22657,40,0.75 [0.49-1.17],0.2069627212254169
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,22644,44,0.97 [0.63-1.48],0.87231520853474
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10847,86,0.79 [0.59-1.06],0.1168052591819483
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22279,1639,1.01 [0.94-1.09],0.7039588707727711
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of meninges,22723,62,1.23 [0.84-1.81],0.2857835583294773
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,22647,76,1.09 [0.77-1.53],0.6201448584747019
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,22711,115,1.06 [0.81-1.39],0.6850641538195472
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of ovary,11823,77,0.99 [0.70-1.40],0.965371800081726
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Ascending colon,22700,434,0.94 [0.82-1.09],0.4133423826914657
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Caecum,22703,375,0.99 [0.85-1.15],0.8604089861079642
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22592,85,0.96 [0.70-1.31],0.7820097173525682
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Descending colon,22697,249,0.96 [0.80-1.16],0.6912203150976941
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Rectum,22657,399,0.94 [0.81-1.08],0.3829474898104454
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22589,656,1.12 [1.00-1.26],0.0503044964359958
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Transverse colon,22681,530,1.11 [0.97-1.26],0.1194261560498657
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Carcinoma in situ of breast,8903,49,1.07 [0.69-1.66],0.7766019681497847
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",8946,65,0.81 [0.57-1.16],0.2512057540117048
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16244,70,1.23 [0.86-1.78],0.2605996980262453
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16270,96,1.20 [0.88-1.65],0.2555078406165938
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",22682,121,0.97 [0.74-1.26],0.7977335447916618
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma, any site",22683,118,0.94 [0.71-1.23],0.6278346241634618
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Leiomyoma of uterus,11555,165,0.82 [0.66-1.01],0.0662565496448368
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Lung cancer and mesothelioma,14411,476,1.12 [0.97-1.28],0.1158791131906363
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Lymphoid leukaemia,16244,70,1.45 [1.00-2.10],0.0477289727854926
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16396,222,0.96 [0.79-1.17],0.6898920814277283
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16485,311,1.22 [1.03-1.46],0.021970096265439
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9023,101,0.73 [0.57-0.92],0.0093887938146018
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16279,105,1.13 [0.84-1.51],0.4330008572424464
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16323,149,1.22 [0.95-1.56],0.1233656142944822
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16297,123,1.21 [0.92-1.59],0.1767119036044846
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9008,86,0.99 [0.72-1.38],0.9673358079327694
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16295,121,0.77 [0.61-0.99],0.0377086664885508
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8195,943,1.01 [0.92-1.12],0.7816652823275675
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16306,132,0.87 [0.67-1.11],0.2631669559456681
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16264,90,1.10 [0.80-1.51],0.5478405366400014
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16319,145,0.93 [0.73-1.20],0.5853707184737222
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi,22594,181,0.91 [0.73-1.13],0.3759883670163459
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi of trunk,22709,76,0.94 [0.67-1.31],0.7147084077547756
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanoma in situ,16225,109,0.92 [0.69-1.22],0.558185961927151
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16292,118,1.19 [0.90-1.59],0.2206281399339915
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16368,194,1.51 [1.21-1.88],0.0003017954807495
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16500,326,1.01 [0.86-1.19],0.8955167733036986
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16300,126,1.54 [1.17-2.03],0.0021968097351323
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Other benign neoplasms of skin,22567,165,1.15 [0.91-1.46],0.2278395351803875
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17629,1455,1.08 [1.00-1.17],0.0596961691781535
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17712,1538,1.07 [0.99-1.16],0.071357211940017
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22429,385,1.31 [1.13-1.53],0.0004242246568267
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20465,162,1.90 [1.52-2.38],1.7978645218791533e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22115,71,1.58 [1.11-2.23],0.0101605330552882
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21984,3428,1.23 [1.16-1.29],1.3998244475575198e-14
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21046,71,1.66 [1.18-2.32],0.0033547236492708
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22277,64,2.23 [1.64-3.04],3.920606914257385e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22229,1926,1.22 [1.14-1.31],7.1164912106475235e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22227,1924,1.22 [1.14-1.31],1.018075360187132e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20416,113,1.32 [0.99-1.75],0.0573437659344302
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22381,1406,1.24 [1.14-1.34],1.294047765253314e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22323,110,1.34 [1.01-1.78],0.0450923617136664
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22117,73,1.34 [0.95-1.90],0.097647635395909
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22118,74,0.99 [0.70-1.40],0.959953352692024
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,22560,347,1.61 [1.38-1.88],1.381842836919706e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,22612,39,1.81 [1.15-2.86],0.010953758540527
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22496,283,1.59 [1.34-1.89],1.33356779154853e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21108,133,1.37 [1.06-1.77],0.0177410526451338
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15225,405,1.40 [1.21-1.62],5.058222172942582e-06
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21276,102,1.10 [0.80-1.50],0.5635405832919054
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21282,108,1.15 [0.86-1.54],0.3375532846921243
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14888,68,1.10 [0.77-1.57],0.6133156599095082
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21114,63,0.82 [0.58-1.16],0.2630634438045905
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20356,316,1.42 [1.20-1.67],3.594328526334462e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",21956,949,1.30 [1.18-1.43],2.035443312647859e-07
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21481,474,1.03 [0.89-1.18],0.7271002133711166
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21221,214,0.99 [0.81-1.21],0.928300850615942
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22451,1400,1.04 [0.96-1.13],0.2841554595441269
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19128,1357,1.06 [0.98-1.15],0.1294467315684155
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14908,88,1.31 [0.96-1.79],0.0911453219262829
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20491,101,1.76 [1.33-2.33],6.863493745613832e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15182,362,1.27 [1.08-1.48],0.0029689302706777
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14874,54,0.91 [0.61-1.35],0.6315030299694169
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19324,4504,0.98 [0.94-1.02],0.3830808030090783
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15080,260,1.24 [1.03-1.49],0.0214383479715575
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15519,699,1.19 [1.06-1.33],0.0024670001996064
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22679,364,1.18 [1.01-1.37],0.042369236706038
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22474,159,1.40 [1.11-1.77],0.0045589636456537
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14970,150,1.16 [0.91-1.48],0.2355194685977829
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14900,80,1.67 [1.22-2.28],0.0014869503197787
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22103,1713,1.15 [1.06-1.23],0.0002737736714511
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15196,376,1.66 [1.44-1.92],4.145543518381373e-12
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15241,421,1.81 [1.59-2.07],1.2872913180580389e-18
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15667,847,0.97 [0.87-1.07],0.5177242637142581
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14992,172,1.11 [0.88-1.40],0.3632791639827731
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22464,149,1.41 [1.11-1.80],0.0049082608630305
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15699,879,1.33 [1.20-1.47],3.706709092459096e-08
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15467,647,1.18 [1.05-1.33],0.0051992371689066
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20119,79,1.52 [1.09-2.10],0.0121773455638279
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21124,6304,1.05 [1.01-1.09],0.0107379685322217
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20449,59,0.93 [0.63-1.37],0.7168972119209511
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20440,50,0.89 [0.58-1.34],0.5678635871183931
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22556,1868,1.01 [0.95-1.08],0.6892002754039418
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22554,1866,1.01 [0.95-1.08],0.7212895192408606
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20456,66,1.11 [0.76-1.60],0.5898613597436112
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22385,1120,0.94 [0.86-1.02],0.1585255705286974
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17017,2197,1.31 [1.23-1.39],9.5532111573431e-17
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,22723,307,1.88 [1.61-2.19],8.718474834827833e-16
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21136,129,1.31 [1.01-1.72],0.0453532125784669
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21382,117,0.94 [0.72-1.24],0.6695751682584766
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21427,162,1.14 [0.90-1.44],0.2831615335840958
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15018,198,1.08 [0.87-1.33],0.4996891040261012
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20001,182,1.64 [1.33-2.02],2.615866271182229e-06
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2421,99,1.68 [1.25-2.25],0.0005208210877239
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2585,303,1.45 [1.22-1.72],1.9199978383566733e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,19903,84,2.49 [1.94-3.19],4.967273076432639e-13
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2394,75,2.62 [1.97-3.48],3.7895535276688936e-11
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21900,2081,1.25 [1.17-1.33],1.5892748232036252e-11
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,21624,617,1.12 [1.00-1.27],0.0596290075861956
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20485,445,1.22 [1.06-1.41],0.0054366066857896
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15909,1089,1.24 [1.13-1.36],2.54260194636986e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22604,300,1.19 [1.00-1.42],0.0499979142389534
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21265,267,1.10 [0.92-1.31],0.3195718219349106
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Angina pectoris,19626,1546,1.04 [0.96-1.12],0.357494889201453
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21368,370,1.13 [0.97-1.32],0.1074682941057385
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21082,84,1.71 [1.26-2.32],0.0006513874819529
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21287,289,1.46 [1.23-1.74],1.650217908379982e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11517,2779,1.20 [1.13-1.27],5.455842185982653e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,AV-block,17267,655,1.19 [1.06-1.34],0.0038479940171526
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22656,572,1.02 [0.90-1.15],0.7656561398062584
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cardiac arrest,9004,266,1.23 [1.03-1.48],0.0231709323909831
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16812,200,1.10 [0.89-1.35],0.3860595548551906
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16719,107,1.15 [0.87-1.54],0.32738918729547
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,22732,79,1.16 [0.83-1.62],0.397488013409459
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Conduction disorders,18133,1521,1.16 [1.08-1.25],0.000115400374759
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20786,2731,1.05 [0.99-1.11],0.088133231751192
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18245,8723,1.08 [1.05-1.12],6.732603173501736e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21194,329,1.21 [1.02-1.43],0.0263729784832498
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Endocarditis,16713,101,1.18 [0.87-1.59],0.2795707902725785
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22449,1640,1.29 [1.20-1.39],1.192899863098116e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertension,19458,7759,1.08 [1.04-1.12],7.695251425662432e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19478,7779,1.08 [1.05-1.12],6.695258669597307e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22568,89,2.39 [1.85-3.08],2.259370481838213e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",11960,261,1.41 [1.19-1.68],0.0001089457250528
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,11907,208,1.89 [1.59-2.25],7.987243933519248e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypotension,22556,1613,1.25 [1.16-1.34],8.347500866501109e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21453,144,1.01 [0.79-1.29],0.9510458514573946
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20953,2873,1.05 [1.00-1.11],0.0683155650629381
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22219,786,1.27 [1.14-1.41],1.3839058258498024e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17126,514,1.25 [1.10-1.43],0.0007909446280582
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22058,1043,1.07 [0.98-1.18],0.1242151799604713
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",18977,897,1.14 [1.04-1.26],0.0079327361486025
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22608,183,0.95 [0.77-1.18],0.6647666174825492
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",22697,399,1.15 [0.99-1.33],0.0735140171000613
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Oesophageal varices,20928,63,2.12 [1.49-3.03],3.3582654759778586e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other aneurysm,21102,104,1.40 [1.05-1.86],0.0230298102359486
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other arrhythmias,17194,582,1.14 [1.01-1.29],0.0368030590230477
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21129,131,1.54 [1.20-1.98],0.0006850634022115
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21323,325,1.26 [1.07-1.49],0.006005349968368
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,16829,217,1.06 [0.86-1.29],0.5939973467341868
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other disorders of veins,20983,118,1.25 [0.95-1.66],0.1133607845346271
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,20911,46,1.19 [0.77-1.85],0.4384790661944503
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,20714,91,0.99 [0.73-1.34],0.9453486342222632
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21042,177,1.04 [0.83-1.30],0.7474173188191658
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18060,1448,1.23 [1.14-1.33],1.8939987460103624e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21002,59,2.53 [1.86-3.43],2.479957917970663e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21720,722,1.27 [1.14-1.42],2.270736931310388e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,21976,527,1.47 [1.29-1.67],4.1598307662432956e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",21584,961,1.19 [1.08-1.31],0.0005368914323714
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9147,409,1.27 [1.09-1.47],0.001512030335154
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21550,587,1.43 [1.27-1.61],5.874533152383828e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21281,416,1.27 [1.10-1.47],0.0015678620978565
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22045,596,1.24 [1.09-1.40],0.0007494557306224
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22637,954,1.29 [1.17-1.42],3.661696776566229e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17120,508,1.18 [1.03-1.34],0.0159412856929407
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Secondary right heart disease,21970,521,1.46 [1.28-1.66],8.697933679307397e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,20883,260,1.36 [1.14-1.64],0.0009060173052816
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22203,894,1.21 [1.10-1.34],0.0001438073656463
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22188,933,1.21 [1.10-1.33],0.0001530598385368
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21422,61,0.93 [0.64-1.36],0.7207796301961993
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21103,105,1.47 [1.10-1.96],0.0090241360063848
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Transient ischemic attack,21754,321,1.00 [0.85-1.18],0.970204969472751
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21343,328,0.95 [0.81-1.11],0.5138948321567225
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Varicose veins,21374,509,1.32 [1.15-1.51],5.843991811389904e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21017,119,1.32 [1.00-1.74],0.0468389175356653
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22468,937,1.24 [1.12-1.36],2.189552981671836e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22656,322,1.10 [0.93-1.30],0.2608875371154813
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19434,1367,0.99 [0.91-1.07],0.8002211119224324
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Any mental disorder,22209,4142,1.04 [1.00-1.09],0.0643290814538225
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22629,381,1.09 [0.94-1.27],0.2652850434514927
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19494,1427,1.05 [0.97-1.14],0.187463654991008
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18150,83,1.08 [0.78-1.50],0.6339150578215598
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Smoking dependency,22228,1141,1.11 [1.02-1.20],0.0148404940913943
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19474,1407,1.07 [0.99-1.15],0.1018797853838753
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Vascular dementia,21852,230,1.16 [0.95-1.42],0.138887436616835
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Alzheimer disease,22735,581,0.97 [0.86-1.10],0.6615900163453742
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",13921,110,1.10 [0.82-1.47],0.5266582433575288
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Bell's palsy,20930,86,1.42 [1.03-1.95],0.030120282210502
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21327,483,1.04 [0.91-1.19],0.5730896762533613
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Cerebral cysts,22299,243,1.22 [1.00-1.48],0.0452908308319016
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22660,407,1.42 [1.22-1.64],2.7378031830500445e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,21899,74,1.05 [0.74-1.48],0.7910750896183232
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,22716,68,1.17 [0.81-1.67],0.4005736903367541
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22140,84,1.58 [1.14-2.19],0.0055896111883741
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Epilepsy,21235,297,1.11 [0.93-1.32],0.2314680138587127
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22273,1335,1.07 [0.99-1.16],0.0884409763859298
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,22680,908,1.03 [0.93-1.14],0.5323065443894609
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22090,3399,1.14 [1.08-1.20],1.0246872633622722e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Generalized epilepsy,22364,52,0.92 [0.61-1.38],0.6760808838350122
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Hemiplegia,22584,331,1.49 [1.27-1.74],1.2867092109368028e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Hydrocephalus,22129,73,0.92 [0.66-1.30],0.6512943273219293
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,22721,72,1.33 [0.93-1.90],0.1149843410614169
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,20907,63,0.88 [0.61-1.28],0.5140087075227913
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,20913,69,1.17 [0.82-1.66],0.3944134170174347
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Memory loss,21603,142,1.15 [0.89-1.48],0.2898517693077811
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Migraine,21217,279,0.96 [0.80-1.15],0.6523291253131415
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22687,255,0.94 [0.78-1.13],0.5125787244766324
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Motor neuron disease,14005,172,1.01 [0.81-1.27],0.9006994695459112
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,22605,60,1.16 [0.79-1.71],0.4423315792380154
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22040,1196,1.04 [0.95-1.13],0.3845551143900825
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Neurological diseases,21263,4287,1.09 [1.04-1.14],0.0001612786261908
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22143,318,1.21 [1.03-1.44],0.024580311740196
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21259,415,1.02 [0.88-1.18],0.7756128227102668
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",22659,346,1.46 [1.25-1.71],2.77676973581639e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16994,958,1.10 [0.99-1.21],0.0670039312304452
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22137,81,1.29 [0.93-1.79],0.1316416604927748
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22213,157,1.14 [0.90-1.45],0.271009744575492
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22003,231,1.22 [1.00-1.49],0.0545079936263927
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other facial nerve disorders,20940,96,1.40 [1.04-1.89],0.0280675650862669
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other headache syndromes,20990,52,0.79 [0.55-1.13],0.1952891593447435
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other neurological diseases,22624,568,1.13 [0.99-1.28],0.0625616596920642
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other sleep disorders,21448,510,1.11 [0.97-1.26],0.1199013326795785
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Parkinson's disease,22701,674,0.99 [0.88-1.11],0.8355455919911543
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22101,45,0.87 [0.57-1.34],0.5333244918472465
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Restless leg syndrome,22735,106,1.39 [1.03-1.85],0.0285009948823404
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Sleep apnoea,22504,434,1.14 [0.99-1.31],0.0678058829460043
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22372,59,1.12 [0.76-1.66],0.5730390143564161
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,22723,200,1.00 [0.81-1.24],0.9764098355641734
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,20911,67,0.92 [0.65-1.31],0.6404066468088385
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,22735,587,0.98 [0.86-1.10],0.704463040836187
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),21792,224,1.18 [0.96-1.44],0.115422536064252
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22100,156,1.03 [0.81-1.31],0.7873670013717923
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22285,549,1.04 [0.91-1.18],0.5840006513773639
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22481,262,1.65 [1.39-1.97],2.1542788570834907e-08
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21528,65,0.76 [0.54-1.09],0.1365645118995647
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21502,39,1.52 [0.94-2.43],0.0846708300608831
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",22614,74,1.27 [0.90-1.80],0.1779946410530723
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22423,219,1.13 [0.92-1.38],0.2544532701659498
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2398,76,2.52 [1.88-3.37],6.54589192734074e-10
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2963,112,1.58 [1.21-2.07],0.0008996400672285
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22048,104,1.04 [0.78-1.39],0.7902261039038757
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22442,1405,1.14 [1.06-1.24],0.0009903745299049
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22329,866,1.05 [0.95-1.16],0.3309533461734302
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,21763,300,1.01 [0.85-1.20],0.8986172265068296
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22662,926,1.02 [0.92-1.12],0.7427151815439248
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,22728,82,1.04 [0.75-1.44],0.8313238501872232
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,22591,855,1.02 [0.92-1.12],0.7696507251667205
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",22694,490,1.10 [0.96-1.26],0.1741986059583894
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,22618,222,0.97 [0.80-1.19],0.7983674103790571
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,21564,101,1.08 [0.80-1.45],0.6236519333514114
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,21563,100,1.21 [0.90-1.63],0.2110818864340524
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21538,75,0.78 [0.57-1.07],0.1230845162581849
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22606,995,0.97 [0.89-1.07],0.572879802984029
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,21870,259,1.04 [0.86-1.25],0.6992577896519241
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,21807,71,1.04 [0.73-1.49],0.8147989101684947
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22327,123,1.06 [0.81-1.38],0.6870117419628834
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,22583,379,1.09 [0.94-1.28],0.2521869193943851
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,21949,213,1.08 [0.88-1.33],0.4493002813174007
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22538,142,1.02 [0.80-1.31],0.8586526914349629
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22279,668,1.02 [0.91-1.15],0.6801022488049882
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22103,159,1.01 [0.80-1.28],0.9397874403125662
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20321,3175,1.08 [1.02-1.14],0.0052296196013279
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,22541,337,1.10 [0.93-1.29],0.262167064944139
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,22722,183,1.19 [0.95-1.48],0.1300216801306758
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,21987,524,1.01 [0.89-1.15],0.8705605675724388
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22295,91,0.88 [0.66-1.19],0.4082545031387603
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,22719,73,1.02 [0.72-1.45],0.8990279407848737
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,21587,124,0.93 [0.72-1.21],0.5889040733496107
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,21630,167,1.04 [0.82-1.30],0.7706295835167403
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21198,161,1.05 [0.83-1.32],0.7122079037763324
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,21799,63,1.15 [0.79-1.68],0.4618672441132007
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21109,72,1.28 [0.90-1.83],0.1699586068479803
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,21725,114,0.79 [0.62-1.02],0.0666305260651282
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",21895,284,0.94 [0.79-1.12],0.5118051126263501
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,21618,155,0.92 [0.72-1.16],0.467961958879412
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21130,93,1.07 [0.78-1.45],0.6844286861687721
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21167,130,0.97 [0.75-1.25],0.8077153894315204
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19837,2691,1.04 [0.98-1.10],0.2320184449112827
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21555,92,1.02 [0.75-1.39],0.9176581749179136
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22446,502,1.07 [0.93-1.22],0.3507391181970094
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22021,77,1.42 [1.01-1.98],0.0420483904603589
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22144,200,1.31 [1.06-1.62],0.0131689657910647
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22520,104,1.14 [0.85-1.53],0.3881069477335316
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,22688,139,1.04 [0.81-1.34],0.7497896098235144
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,22603,117,0.92 [0.70-1.21],0.5540764008399033
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22479,63,1.00 [0.69-1.46],0.9840144753350905
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,22483,67,0.86 [0.60-1.22],0.3869481492703258
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,22630,1212,1.14 [1.04-1.24],0.0034017050667496
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22333,915,1.13 [1.02-1.24],0.0191103844507898
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,21569,151,1.18 [0.92-1.50],0.1899459981764035
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21506,88,1.25 [0.91-1.72],0.1711607232752958
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute pharyngitis,22546,67,1.23 [0.85-1.78],0.2652234964498802
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22663,184,1.45 [1.16-1.80],0.0009039358032772
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22542,63,1.78 [1.26-2.53],0.0012156264693737
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,All influenza,20106,153,1.78 [1.41-2.25],1.0052350463885122e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20103,150,1.82 [1.45-2.30],3.7007778924254393e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14031,96,0.88 [0.66-1.19],0.4113113353809666
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Allergic rhinitis,22633,234,1.02 [0.84-1.24],0.8295224008242786
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15219,1670,1.09 [1.02-1.18],0.0186390809705148
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15583,1648,1.10 [1.02-1.18],0.0176351643587521
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22230,174,1.55 [1.24-1.93],0.0001074937750208
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20055,102,1.22 [0.91-1.65],0.1863194928309124
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Bronchiectasis,19091,506,1.23 [1.08-1.41],0.0021684722310571
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",18655,70,1.21 [0.85-1.74],0.287896283089896
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21636,3051,1.13 [1.07-1.19],9.077355694789382e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21531,70,0.98 [0.69-1.40],0.9172679541634464
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic sinusitis,21591,130,0.96 [0.74-1.24],0.7449862056704954
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22449,1596,1.20 [1.11-1.29],1.3724131776523276e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Deviated nasal septum,21541,80,0.88 [0.64-1.22],0.4490950939246808
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20625,5993,1.15 [1.10-1.19],4.825325108209804e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",21796,335,1.09 [0.93-1.28],0.2955791544338135
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Early onset COPD,20960,107,1.21 [0.91-1.61],0.1890115920429309
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Emphysema,19008,423,1.34 [1.16-1.54],5.069709631509845e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21471,447,1.58 [1.38-1.81],6.469363966913757e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22479,2526,1.29 [1.22-1.37],5.849171378866386e-17
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Interstitial lung disease,21512,488,1.60 [1.41-1.82],1.6141184819993652e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Later onset COPD,22219,1489,1.20 [1.11-1.30],2.604697710173489e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,22719,498,1.22 [1.07-1.40],0.0038344086540315
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Nasal polyp,21556,95,0.90 [0.67-1.21],0.4820010237974345
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22458,1275,1.35 [1.24-1.46],3.0739354798275165e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of pleura,22447,2629,1.25 [1.18-1.33],3.9518830080635974e-14
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22200,739,1.01 [0.91-1.13],0.8460192478931392
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other pleural conditions,19883,65,1.13 [0.78-1.64],0.5331235120038142
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22617,580,1.59 [1.41-1.79],4.3206245519307683e-14
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22609,1685,1.29 [1.20-1.39],3.412754506662474e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural effusion,21162,1344,1.23 [1.13-1.33],8.528946228072104e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural plaque,20063,245,1.24 [1.02-1.50],0.0306504204705213
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22200,2247,1.30 [1.22-1.39],3.193546307965221e-16
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,22608,387,1.25 [1.07-1.46],0.0045730595143066
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pneumothorax,19983,165,1.16 [0.92-1.47],0.2009044848705841
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pollen allergy,22727,199,1.03 [0.83-1.27],0.7983798452876322
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pulmonary oedema,22127,90,1.85 [1.38-2.47],3.199043652211955e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14004,69,1.41 [0.98-2.02],0.0627873739247071
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22437,1254,1.35 [1.24-1.47],2.080007506468698e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,21697,236,1.03 [0.85-1.24],0.7908091068602288
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Viral pneumonia,20251,298,1.32 [1.11-1.57],0.0019274128523553
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22237,238,1.29 [1.07-1.57],0.0092368942738559
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7251,119,1.08 [0.83-1.42],0.5636592787979702
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14430,60,1.14 [0.78-1.67],0.4924831738467673
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute appendicitis,22620,126,0.90 [0.70-1.17],0.439999078123625
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute gastritis,15804,101,1.03 [0.77-1.38],0.8432384924448489
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute pancreatitis,20734,196,1.32 [1.07-1.63],0.0107786080284505
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute peritonitis,22253,107,1.17 [0.87-1.55],0.2980470836222107
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Alcoholic liver disease,21777,59,2.26 [1.63-3.13],1.1281078125312665e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Barrett oesophagus,16204,501,1.07 [0.93-1.22],0.3353728615531506
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",20681,143,0.96 [0.75-1.22],0.7104561670798677
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22322,143,0.94 [0.74-1.19],0.6019611722393081
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholecystitis,20758,220,1.16 [0.95-1.42],0.1429966952291793
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholelithiasis,21571,1033,1.33 [1.21-1.46],2.2400114549058656e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Chronic gastritis,16047,344,1.10 [0.94-1.29],0.2357794576697937
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Chronic pancreatitis,20594,56,1.11 [0.74-1.66],0.6098536143768933
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22600,121,2.32 [1.86-2.90],1.1158107843493752e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Coeliac disease,21020,126,1.68 [1.29-2.18],9.515395583269186e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Collagenous colitis,21038,101,0.92 [0.68-1.23],0.5547107597012464
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22621,154,1.22 [0.96-1.55],0.1013834145754195
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Constipation,22454,2084,1.13 [1.06-1.21],0.0001789949278518
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn disease,21024,87,1.78 [1.31-2.42],0.0002196191776223
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22391,68,1.47 [1.03-2.10],0.0354353964495595
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21017,80,1.88 [1.37-2.57],9.301189252081502e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Dental caries,22130,182,1.15 [0.93-1.44],0.2020952926402875
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19630,2528,1.01 [0.96-1.08],0.6593742239728522
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of appendix,22650,156,0.94 [0.74-1.18],0.5847293079732425
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of liver,22617,899,1.31 [1.18-1.44],1.1889661073447529e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20218,4515,1.03 [0.99-1.08],0.1436773771362156
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22410,462,1.23 [1.07-1.41],0.0036334345682924
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22645,499,1.22 [1.06-1.39],0.0042369752472464
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22042,94,1.46 [1.08-1.98],0.0151081052048465
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of salivary glands,21913,59,1.35 [0.92-1.98],0.1273419403646435
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22406,1512,1.20 [1.11-1.29],4.1208993627532815e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of tongue,21931,93,1.22 [0.89-1.66],0.2165852895492144
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22030,1492,1.27 [1.18-1.37],1.5003909817974447e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18061,3691,1.07 [1.02-1.13],0.0044211758651348
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Duodenal ulcer,15953,250,1.05 [0.87-1.27],0.588819973614005
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22640,202,0.99 [0.80-1.21],0.89505777020115
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,22700,26,1.10 [0.61-1.98],0.7556615056310554
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,21861,143,2.19 [1.78-2.71],2.157345703804625e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14476,106,1.14 [0.86-1.52],0.3640387532907407
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Functional dyspepsia,16258,555,1.06 [0.93-1.20],0.4046718060315868
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastric ulcer,16124,421,1.24 [1.07-1.43],0.0037740635184773
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18323,2620,1.00 [0.94-1.06],0.9930555555513462
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16346,643,1.13 [1.00-1.27],0.0432873485428008
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16418,8064,1.10 [1.06-1.14],3.787274104771698e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,GI-bleeding,22148,1254,1.16 [1.06-1.26],0.0007774631708735
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,21991,43,0.89 [0.59-1.36],0.5943267308632767
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15342,1161,1.02 [0.93-1.11],0.6883139982248296
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",21786,68,1.72 [1.22-2.42],0.0019226276679169
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Hernia,20707,3605,1.01 [0.96-1.06],0.7245081987825779
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Impacted teeth,22704,24,1.06 [0.57-1.96],0.851546390178304
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Impaction of intestines,14447,77,1.38 [0.98-1.95],0.0649969328357614
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Inguinal hernia,18188,1086,0.95 [0.87-1.04],0.2629244021233023
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17223,121,0.89 [0.68-1.16],0.3987513195893355
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14485,115,1.59 [1.21-2.10],0.0008599838753132
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21039,145,1.66 [1.31-2.12],3.803204346609206e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14873,503,1.02 [0.89-1.17],0.7668931699224324
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,22705,334,1.26 [1.07-1.48],0.0055211459189085
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,21695,758,1.32 [1.19-1.48],3.351447817800392e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,21994,1057,1.22 [1.11-1.34],1.975187837690901e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15921,218,1.08 [0.88-1.32],0.4591082254233426
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophagitis,16390,687,1.08 [0.96-1.21],0.1956118462563869
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,22682,134,0.99 [0.77-1.28],0.9343798563498448
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17189,87,0.92 [0.67-1.26],0.5862704428415013
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15711,1341,1.11 [1.02-1.20],0.0131939202516039
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,20893,355,1.08 [0.92-1.27],0.3365861352286652
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,20684,146,1.19 [0.93-1.52],0.1688640440175145
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestine,16272,1902,1.09 [1.02-1.17],0.0125514969752674
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestines,20445,6075,1.11 [1.06-1.15],2.343923979705997e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,21894,208,1.04 [0.85-1.28],0.6819389610889346
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of liver,22458,740,1.35 [1.21-1.50],1.0051879552306017e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16460,757,1.04 [0.94-1.16],0.4519550585423275
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of pancreas,20746,208,1.32 [1.07-1.62],0.0087231468140991
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22571,425,1.21 [1.04-1.40],0.0106711670271689
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16774,1071,1.14 [1.04-1.25],0.006065129520047
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22165,1271,1.16 [1.06-1.26],0.0005905705717821
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22124,176,1.20 [0.96-1.50],0.1142104542048402
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16498,2128,1.16 [1.09-1.24],4.696698455936007e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17833,2130,1.07 [1.00-1.14],0.0503056265156355
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,21827,109,1.46 [1.10-1.92],0.0078756026112498
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,21868,931,1.26 [1.14-1.39],3.558532489937602e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14809,439,1.24 [1.08-1.44],0.0026885789996046
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,22696,29,1.07 [0.61-1.86],0.8224084051524843
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14978,608,1.26 [1.11-1.42],0.0002356966379722
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21049,155,1.25 [0.99-1.59],0.0646328468597116
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Recurring oral aphthae,22723,51,1.22 [0.80-1.87],0.354186858491075
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,21941,100,1.45 [1.08-1.95],0.0144502051455923
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Toxic colitis,21016,79,1.19 [0.84-1.67],0.324240740765859
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16043,340,1.07 [0.91-1.25],0.4384942798686752
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcerative colitis,21099,162,1.04 [0.83-1.32],0.7244045077032318
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21065,128,1.12 [0.86-1.46],0.4057401567212699
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Umbilical hernia,17356,254,1.11 [0.92-1.33],0.2799938184252643
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14610,240,1.31 [1.08-1.59],0.0061521376382569
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ventral hernia,17390,288,1.19 [0.99-1.41],0.0581321151600516
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Volvulus,14464,94,0.99 [0.73-1.33],0.922879708441821
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,22630,419,1.11 [0.96-1.29],0.1613137361269385
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22379,64,1.24 [0.85-1.80],0.2662617998834724
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20195,164,1.08 [0.85-1.37],0.5212442365135901
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22110,806,1.24 [1.12-1.38],5.1619041081556514e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21445,141,1.31 [1.02-1.68],0.0369276815628966
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,20657,626,1.35 [1.20-1.53],6.519016936409309e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22402,315,1.17 [0.99-1.38],0.0658825916624569
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22638,551,1.20 [1.06-1.36],0.0046629935969581
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22133,46,1.51 [0.98-2.33],0.0619464531830037
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21158,3677,1.15 [1.09-1.21],3.3881773986051775e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22308,431,1.03 [0.89-1.18],0.7288410594569034
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22178,301,0.92 [0.78-1.09],0.3240980595097138
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22357,1053,1.20 [1.10-1.32],8.343890520147073e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",22715,59,0.89 [0.61-1.30],0.5535487941484194
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20087,56,1.63 [1.11-2.39],0.0121084109009762
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,21939,62,1.21 [0.83-1.77],0.3194735383557351
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22388,301,1.17 [0.99-1.39],0.0670716825572124
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20631,600,1.22 [1.08-1.38],0.0016050040967924
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20121,90,1.16 [0.85-1.59],0.3495740796233543
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,22647,94,1.01 [0.74-1.36],0.969526873845212
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21539,235,1.38 [1.13-1.67],0.0012359259605788
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22534,219,1.04 [0.85-1.27],0.6892155248119247
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22182,95,1.09 [0.80-1.47],0.5854292546432989
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20112,81,1.08 [0.77-1.50],0.659994080265809
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22125,2094,1.19 [1.11-1.27],3.271150909725453e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20675,644,1.22 [1.09-1.38],0.0008209158904855
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20124,93,1.18 [0.87-1.61],0.2859762404000751
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22645,330,1.01 [0.86-1.19],0.8883262039450931
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22160,73,1.51 [1.07-2.13],0.0180730377249881
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22585,270,1.04 [0.87-1.25],0.6563668544610064
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22662,451,1.13 [0.98-1.30],0.1015277200985684
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20155,124,1.10 [0.84-1.44],0.4975762436464482
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20370,339,1.02 [0.86-1.19],0.855666315984988
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22650,439,1.14 [0.98-1.31],0.0805031613274778
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20364,333,1.49 [1.27-1.75],7.127804215648944e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,22709,156,1.15 [0.91-1.46],0.2448167153474383
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,18947,78,1.13 [0.81-1.59],0.4614514503325657
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20036,6313,1.08 [1.04-1.13],3.557429893995817e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18650,4927,1.06 [1.02-1.11],0.0063875158214898
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,18920,51,0.96 [0.64-1.43],0.8341991696322792
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18870,144,0.98 [0.77-1.25],0.874457893522342
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18917,191,1.10 [0.88-1.36],0.3994812193635132
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22478,64,0.81 [0.58-1.13],0.2224821843670864
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",18876,150,1.42 [1.11-1.82],0.0051473664878504
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15185,1462,1.03 [0.96-1.12],0.4013476044277502
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22529,242,1.01 [0.83-1.22],0.9191767815681564
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19299,573,1.06 [0.93-1.20],0.3708102724234565
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18396,7874,1.08 [1.04-1.11],1.5168699286877598e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20247,119,1.26 [0.95-1.66],0.1036211287849543
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19049,180,1.14 [0.91-1.42],0.2502238559994152
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19373,504,1.03 [0.90-1.18],0.6457019392022871
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21816,3090,1.09 [1.03-1.15],0.0014817697649153
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19173,304,1.26 [1.06-1.49],0.0088888661872043
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19017,148,0.85 [0.68-1.06],0.1508175987717437
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,18984,115,1.31 [0.99-1.74],0.0577019827908108
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22000,97,1.13 [0.83-1.53],0.4505981187826946
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15696,1973,1.04 [0.97-1.11],0.2421244002628201
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14508,785,1.23 [1.10-1.37],0.0001775465623683
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22639,777,1.19 [1.07-1.33],0.0011354558338364
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,13798,75,0.68 [0.51-0.91],0.0084769517491639
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14021,298,1.11 [0.93-1.32],0.2576940299763989
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19132,263,0.94 [0.78-1.12],0.4846544126524948
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14195,472,0.89 [0.78-1.02],0.0815826757143917
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,18803,77,1.54 [1.10-2.17],0.0118101419393203
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19397,671,1.06 [0.94-1.18],0.3456894083703556
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19032,306,0.99 [0.84-1.18],0.9433342205756656
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14165,442,0.90 [0.78-1.03],0.1198297624703652
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,18936,67,1.19 [0.83-1.73],0.3446469905763539
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",18929,60,1.16 [0.79-1.70],0.4564721191299334
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20211,83,1.44 [1.04-1.99],0.0259919793289219
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22307,2179,1.13 [1.06-1.21],0.0001627981386909
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21658,1530,1.17 [1.08-1.26],0.000106102807566
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22564,527,1.29 [1.13-1.47],0.0001115203812237
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16795,3072,1.09 [1.04-1.15],0.0013779701064809
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,13764,41,0.78 [0.50-1.22],0.2806797639725594
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,18971,102,0.88 [0.67-1.16],0.3674068370003429
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,13789,66,2.03 [1.41-2.91],0.0001400377611872
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),13855,132,1.15 [0.88-1.50],0.3137789783317626
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20366,238,0.93 [0.77-1.13],0.4704335199898337
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,20624,496,1.16 [1.01-1.34],0.0304733812617748
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,22711,110,1.13 [0.85-1.51],0.3905905007556798
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20674,1948,1.07 [1.00-1.14],0.0462247764345558
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,18941,72,1.18 [0.82-1.68],0.3733863036097314
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),13877,154,1.27 [0.98-1.63],0.0660859559374161
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19495,769,1.00 [0.90-1.11],0.988596410348409
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15875,2152,1.09 [1.02-1.16],0.0138855124646617
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22025,122,1.16 [0.89-1.53],0.275912959054442
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,22723,61,1.31 [0.89-1.92],0.1687399474196872
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,18946,77,1.06 [0.76-1.49],0.7295184314782268
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20190,1321,1.16 [1.06-1.25],0.0005620339867117
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,18975,106,1.21 [0.90-1.63],0.1999617846533312
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15747,2024,1.05 [0.98-1.13],0.1356487824973838
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20246,118,0.79 [0.61-1.02],0.073680964920758
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,18907,38,1.17 [0.71-1.91],0.5352394250841035
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,18916,190,1.07 [0.86-1.32],0.5621748041179017
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19540,671,1.21 [1.08-1.36],0.0014591502243093
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22389,486,1.17 [1.02-1.34],0.0287933874732843
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19376,650,1.21 [1.08-1.36],0.0012630007052796
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22579,523,1.30 [1.14-1.49],7.108439451924408e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,22709,67,1.82 [1.29-2.55],0.0005601389265723
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19034,165,0.88 [0.71-1.10],0.2644821780437135
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17685,876,1.14 [1.03-1.26],0.0111980583445062
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19499,630,1.14 [1.01-1.28],0.0340039465063317
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19142,273,1.21 [1.01-1.45],0.0362053119410964
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",13794,71,1.34 [0.93-1.93],0.1180679127625618
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16782,3059,1.11 [1.05-1.17],0.0002808398986909
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14547,824,1.08 [0.97-1.20],0.1581357356435917
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22277,374,1.07 [0.91-1.25],0.4118069581149106
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",22679,78,1.05 [0.75-1.48],0.7809149733098139
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20119,70,0.90 [0.66-1.21],0.4782872678436413
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,13785,62,1.33 [0.90-1.96],0.1524929517388472
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,18830,104,0.97 [0.73-1.30],0.8637812756286469
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14257,534,1.32 [1.16-1.51],3.415100191119888e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19199,330,0.99 [0.84-1.16],0.8794225539975097
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19008,282,0.94 [0.79-1.11],0.451005200116873
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,18988,262,1.06 [0.88-1.27],0.5582441506473727
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15995,64,1.23 [0.84-1.79],0.2814538323045695
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",22714,72,1.78 [1.28-2.48],0.0005916901036266
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19413,544,1.02 [0.90-1.16],0.7591118811006221
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],21993,90,1.89 [1.40-2.54],2.876259753772528e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21462,2593,1.11 [1.05-1.18],0.0005688383590539
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19017,148,1.18 [0.92-1.52],0.1832333685150813
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19432,706,1.21 [1.08-1.36],0.0008452830409804
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21393,263,1.08 [0.90-1.30],0.4071999762763125
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,18977,251,0.92 [0.77-1.10],0.3657888599765054
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20698,1972,1.13 [1.06-1.21],0.0003602570348836
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20016,1290,1.12 [1.03-1.22],0.0069611953409751
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],18930,61,0.81 [0.59-1.13],0.2215696003980234
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22012,109,1.98 [1.52-2.57],3.316738113651288e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19031,162,1.07 [0.84-1.35],0.5990594639782307
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,18960,91,1.27 [0.93-1.75],0.1378659859207417
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),13798,75,1.26 [0.89-1.79],0.1931116401894051
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21255,2214,1.45 [1.36-1.55],8.257553543950783e-31
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9083,24,0.84 [0.46-1.52],0.5594031960349836
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11531,33,0.72 [0.45-1.13],0.1494080697482792
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22410,304,0.99 [0.84-1.17],0.8982348285841868
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22210,104,1.31 [0.98-1.76],0.0657941520381292
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21333,2292,1.46 [1.38-1.56],2.3766993421276844e-33
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22501,127,1.61 [1.25-2.06],0.0001789244161493
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22427,399,1.27 [1.09-1.48],0.0017111682866473
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Cystitis,18933,297,1.10 [0.92-1.30],0.2990841794671662
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Dialysis,19140,99,2.63 [2.08-3.33],5.490500287627322e-16
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10033,2099,1.01 [0.95-1.08],0.7174652257258469
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11632,134,1.03 [0.80-1.33],0.8196614413588525
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Endometriosis,9096,37,0.90 [0.56-1.43],0.6485114807328197
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9635,576,1.06 [0.94-1.21],0.3318238270382234
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18716,6167,1.11 [1.07-1.16],3.639701992631073e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22470,96,2.24 [1.75-2.87],1.4054857401875468e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hydrocele,8053,119,0.87 [0.67-1.13],0.2912657319348425
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19109,344,1.14 [0.97-1.35],0.106735623372375
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9724,1790,1.03 [0.96-1.10],0.3783158642991726
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11698,153,0.89 [0.70-1.12],0.3171441920567023
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8059,125,0.90 [0.69-1.15],0.3932235522242026
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18726,90,1.01 [0.74-1.37],0.9664840454560684
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10074,1015,1.03 [0.94-1.13],0.569569558607276
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,7994,60,0.76 [0.54-1.06],0.1048314957804477
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9096,37,1.04 [0.65-1.68],0.8627574387687159
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",22720,86,0.97 [0.71-1.33],0.8547801714358295
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",22721,85,1.24 [0.90-1.72],0.1875876236683425
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21542,2906,1.09 [1.03-1.15],0.0022653228474431
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19563,927,1.04 [0.95-1.15],0.4043549252387263
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11550,52,1.33 [0.88-2.01],0.1786741041264871
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22650,622,1.35 [1.20-1.52],8.860129704118188e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8086,152,1.14 [0.90-1.45],0.2646832230243735
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8094,160,0.91 [0.73-1.14],0.4154869227821373
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8080,146,1.09 [0.85-1.39],0.4953226789312625
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,22693,86,1.10 [0.79-1.51],0.5779617305657904
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,20950,2314,1.15 [1.08-1.22],9.14795621671948e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11623,78,0.98 [0.70-1.37],0.9116880179669676
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9125,66,0.91 [0.64-1.31],0.6166523354598641
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9195,136,0.88 [0.69-1.12],0.2990527139734389
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9109,50,1.11 [0.72-1.71],0.6451991292109567
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9158,99,0.78 [0.60-1.03],0.0792421156337391
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19173,408,1.10 [0.95-1.28],0.200175530895871
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22231,203,1.43 [1.16-1.76],0.0007408808628471
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9181,122,0.98 [0.75-1.28],0.8775125095995773
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9084,25,0.58 [0.38-0.89],0.0120562994816912
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9261,202,0.81 [0.68-0.97],0.0189293069980654
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9151,92,0.92 [0.68-1.25],0.5954501852670616
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9257,198,0.97 [0.79-1.19],0.7654863303494182
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22422,48,1.54 [1.01-2.37],0.0471534698210449
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8087,153,1.02 [0.81-1.29],0.8508393347163965
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22446,3681,1.31 [1.25-1.38],4.520365990476932e-27
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",18858,93,1.25 [0.91-1.72],0.1694194935841181
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19222,181,2.02 [1.65-2.48],1.1703473473805112e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22146,40,1.48 [0.94-2.34],0.0940044579586183
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18894,258,0.96 [0.80-1.15],0.6654177195246664
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22497,391,1.07 [0.92-1.24],0.4064945574251797
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9095,36,0.75 [0.54-1.04],0.0894348583028271
